Adverts

Open Access Articles- Top Results for Binimetinib

Binimetinib

</th></tr>
Binimetinib
File:Binimetinib.png
Systematic (IUPAC) name
5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide
Clinical data
Trade names Binimetinib
  • Investigational
Identifiers
606143-89-9
None
PubChem CID 10288191
Chemical data
Formula C17H15BrF2N4O3
441.23 g/mol

Binimetinib (MEK162, ARRY-162) is a MEK inhibitor being developed by Array Biopharma. It is currently in phase 3 clinical trials for ovarian cancer, BRAF mutant melanoma, and NRAS mutant melanoma. [1]

References

  1. "Array biopharma:: Binimetinib" [1]

Lua error in package.lua at line 80: module 'Module:Buffer' not found.